QUANTUM BIOPHARMA-B SUB VOT (QNTM) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:QNTM • CA74764Y2050

4.87 USD
-0.04 (-0.81%)
At close: Jan 29, 2026
4.81 USD
-0.06 (-1.23%)
After Hours: 1/29/2026, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 33.28. This target is 583.47% above the current price.
  • QNTM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNTM.
  • In the previous month the buy percentage consensus was at a similar level.
  • QNTM was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

QNTM Historical Analyst RatingsQNTM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.8732.9633.2833.2834.26 - 576.77% 583.47% 583.47% 603.57%

Related screens

QNTM Current Analyst RatingQNTM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

QUANTUM BIOPHARMA-B SUB VOT / QNTM FAQ

What do analysts expect the price target to be for QUANTUM BIOPHARMA-B SUB VOT (QNTM)?

7 analysts have analysed QNTM and the average price target is 33.28 USD. This implies a price increase of 583.47% is expected in the next year compared to the current price of 4.87.


How do analysts rate QUANTUM BIOPHARMA-B SUB VOT (QNTM)?

The consensus rating for QUANTUM BIOPHARMA-B SUB VOT (QNTM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.